Product Name: Cathelicidin (134-170)
Product Number: PE-01AAE95
Size: | 200 µg | | Price: | 118.00 |
| 1 mg | | $US | 237.00 |
| 5 mg | | | 518.00 |
Peptide Name: Cathelicidin (134-170)
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 4492.2 Da
Peptide Purity Percent after Synthesis and Purification: >95
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
Scientific Background: Antimicrobial peptide LL-37, belonging to the cathelicidin family, is the first amphipathic alpha-helical peptide isolated from humans. LL-37 plays an important role in the first line of defense against local infection and systemic invasion of pathogens at sites of inflammation and wounds. It is cytotoxic to both bacterial and normal eukaryotic cells. LL-37 is significantly resistant to proteolytic degradation in solution.
[4] Dürr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta. 2006 Sep;1758(9):1408-25. Epub 2006 Apr 4. PMID: 16716248. [5] Neville F, Cahuzac M, Konovalov O, Ishitsuka Y, Lee KY, Kuzmenko I, Kale GM, Gidalevitz D. Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism of action. Biophys J. 2006 Feb 15;90(4):1275-87. Epub 2005 Nov 18. PMID: 16299073. [6] Oren Z, Lerman JC, Gudmundsson GH, Agerberth B, Shai Y. Structure and organization of the human antimicrobial peptide LL-37 in phospholipid membranes: relevance to the molecular basis for its non-cell-selective activity. Biochem J. 1999 Aug 1;341 ( Pt 3):501-13. PMID: 10417311.